Literature DB >> 9113096

Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection.

G Baier-Bitterlich1, D Fuchs, H Wachter.   

Abstract

Infection with the human immunodeficiency virus (HIV) is accompanied by a decrease in CD4+ T cell numbers and the ultimate disruption of immunological functions. In sera of infected patients, elevated levels of interferon-gamma are detected, which is indicative of an activated TH1-type immune response. T-cell-derived interferon-gamma leads to the expression of various proinflammatory cytokines and enhanced macrophage capacity to secrete reactive oxygen intermediates. In addition, interferon-gamma is the major stimulator for the biosynthesis of neopterin and its reduced form, 7,8-dihydroneopterin. Neopterin is known as a sensitive immune activation marker in clinical laboratory diagnosis. Recent data implied a potential role of neopterin derivatives in oxygen free-radical-mediated processes, e.g. high concentrations of 7,8-dihydroneopterin were found to interfere with the oxidant-antioxidant balance, and may lead to apoptosis of human cells. In addition, 7,8-dihydroneopterin was found to be effective in the activation of redox-sensitive transcription factors and in the induction of HIV-1 gene expression. In this commentary, we describe our current view as to how neopterin derivatives, in concert with cytokines and reactive oxygen intermediates, may lead the way to the final destruction of the cellular immune system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9113096     DOI: 10.1016/s0006-2952(96)00651-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  15 in total

1.  Gamma interferon is dispensable for neopterin production in vivo.

Authors:  R Sghiri; J Feinberg; F Thabet; K Dellagi; J Boukadida; A Ben Abdelaziz; J L Casanova; M R Barbouche
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

2.  Oxidative modifications of kynostatin-272, a potent human immunodeficiency virus type 1 protease inhibitor: potential mechanism for altered activity in monocytes/macrophages.

Authors:  David A Davis; Elizabeth Read-Connole; Kara Pearson; Henry M Fales; Fonda M Newcomb; Jackob Moskovitz; Robert Yarchoan
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 3.  Repression of gene expression by oxidative stress.

Authors:  Y Morel; R Barouki
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

4.  Antioxidative capacity in patients with common variable immunodeficiency.

Authors:  J Reichenbach; R Schubert; C Schwan; K Müller; H J Böhles; S Zielen
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

5.  Enhanced interferon-gamma by CD8+ CD28- lymphocytes from HIV+ patients.

Authors:  E H Eylar; C Lefranc; I Báez; S L Colón-Martinez; Y Yamamura; N Rodriguez; N Yano; T B Breithaupt
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

6.  Anti-oxidative capacity in patients with ataxia telangiectasia.

Authors:  J Reichenbach; R Schubert; C Schwan; K Müller; H J Böhles; S Zielen
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

7.  Allergenic sensitization prevents upregulation of haemopoiesis by cyclo-oxygenase inhibitors in mice.

Authors:  Letícia Lintomen; Maria Ignez C Gaspar Elsas; Elisabeth Santos Maximiano; Heitor Affonso de Paula Neto; Danielle Joseph; B Boris Vargaftig; P Xavier Elsas
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

8.  Multiparameter analysis of clastogenic factors, pro-oxidant cytokines, and inflammatory markers in HIV-1-infected patients with asymptomatic disease, opportunistic infections, and malignancies.

Authors:  J Fuchs; N Oelke; M Imhof; F Ochsendorf; H Schöfer; G Oromek; A Alaoui-Youssefi; I Emerit
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

9.  Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection.

Authors:  Yolanda Guillén; Marc Noguera-Julian; Javier Rivera; Maria Casadellà; Alexander S Zevin; Muntsa Rocafort; Mariona Parera; Cristina Rodríguez; Marçal Arumí; Jorge Carrillo; Beatriz Mothe; Carla Estany; Josep Coll; Isabel Bravo; Cristina Herrero; Jorge Saz; Guillem Sirera; Ariadna Torrella; Jordi Navarro; Manuel Crespo; Eugènia Negredo; Christian Brander; Julià Blanco; Maria Luz Calle; Nichole R Klatt; Bonaventura Clotet; Roger Paredes
Journal:  Mucosal Immunol       Date:  2018-08-31       Impact factor: 7.313

Review 10.  Immunopharmacology of hypersensitivity reactions to drugs.

Authors:  Dean J Naisbitt; Munir Pirmohamed; B Kevin Park
Journal:  Curr Allergy Asthma Rep       Date:  2003-01       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.